Amed Co., Ltd. (7575) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Amed Co., Ltd. (7575:TWSE), powered by AI.

Current Price
$18.40
Sector
Healthcare
What is the Amed Co., Ltd. stock price forecast?

Amed Co., Ltd. is currently trading at $18.40. View real-time AI analysis on Alpha Lenz.

What is Amed Co., Ltd. insider trading activity?

View the latest insider trading data for Amed Co., Ltd. on Alpha Lenz.

What is Amed Co., Ltd.'s P/E ratio?

View Amed Co., Ltd.'s valuation metrics on Alpha Lenz.

Amed Co., Ltd.

TWSE · 7575
NT$18.40+0.35(+1.94%)
Ask about Amed Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Amed Co., Ltd.'s ROE is 8.9%. Explore profitability and growth together.

Ask for details

Company Overview

Amed Co., Ltd. is a healthcare company specializing in the research, development, manufacturing, and distribution of medical equipment and consumables. Founded in 2008 and headquartered in New Taipei City, Taiwan, the company operates through three core business platforms: wound care, pain-free medical solutions, and medical device support. Its wound care platform delivers advanced solutions such as high-end wound dressings under the HERADERM brand and negative pressure wound therapy systems, addressing a broad spectrum of wound management needs. The pain-free medical platform provides long-acting pain relief products, including 7-day injectable formulations like those marketed under the Naldebain brand, facilitating smoother post-operative recovery. The medical device support platform encompasses innovative tools such as implantable port kits and artificial blood vessels, designed to simplify clinical procedures and support healthcare providers. Amed Co., Ltd.’s portfolio is distributed both domestically and internationally, contributing to sectors such as hospitals, clinics, and specialist medical settings. With an emphasis on innovation and quality, the company plays a notable role in the medical instruments and supplies industry, serving the growing demands of modern healthcare systems.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$821.96MRevenue
0.00Shares Out
0Employees

Margins

67.14%Gross
13.07%EBITDA
9.29%Operating
6.80%Pre-Tax
4.35%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

6.02%Rev 3Yr
11.59%Rev 5Yr
-11.99%Op Inc 3Yr
5.77%Op Inc 5Yr
-22.62%Net Inc 3Yr
-0.18%Net Inc 5Yr

Returns

3.13%ROA
8.91%ROE
5.94%ROIC

Financial Health

NT$78.66MCash & Cash Equivalents
NT$665.95MNet Debt
187.54%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Amed Co., Ltd. (ticker: 7575) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 18.4 with a P/E ratio of -x and P/B of -x.

ROE is 8.91% and operating margin is 9.29%. Annual revenue is $822M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Amed Co., Ltd. (7575) Stock Forecast 2026 $18.40 — Price, Financials & Analyst Targets | Alpha Lenz